Chromosomal translocation products engender new intracellular therapeutic technologies.

Chromosomal translocations occur in leukemias, lymphomas, sarcomas and some epithelial tumors and some generate unique fusion proteins. These translocation products may provide tumor-specific targets for the development of new therapeutic strategies tailored to a malignant cell.

Библиографические подробности
Главные авторы: Rabbitts, T, Stocks, MR
Формат: Journal article
Язык:English
Опубликовано: 2003

Схожие документы